FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, more specifically to a pharmaceutical composition of choline alphoscerate in the form of a solution for injections exhibiting nootropic activity and cholinomimetic action. The pharmaceutical composition contains choline alphoscerate in the therapeutically effective amount as an active ingredient and povidone (plasdone or collidone) in the amount 0.2-0.8 wt % at 100% of the whole composition as a pharmaceutically acceptable carrier. The pharmaceutical composition under the invention is used for treatment or prevention of CNS diseases and effects of craniocereberal injures.
EFFECT: pharmaceutical composition under the invention keeps prolonged storage stability, exhibits minimum by-effects and improved bioavailability.
5 cl, 1 tbl
